secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2026-06-16T16:05:48+00:00
Accession:  0001140361-26-025363
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics holds R&D Science Forum; presentation content not disclosed in filing excerpt
--------------------------------------------------------------------------------

- Company delivered a corporate presentation at its Virtual R&D Science Forum on June 16, 2026.
- Presentation is accessible via the investor relations section of the company's website.
- No specific pipeline data, financials, or material updates from the presentation are included in the filing excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126025363/0001140361-26-025363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126025363/ef20076261_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-025363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer